HIGHLIGHTS
- who: Pierre Branger and colleagues from the Department of Neurology, University Hospital of Caen, Caen, France, Biostatistics and clinical research have published the research: The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0149685]. March 16, 2016 of November/29,/2015
- what: Search strategy and selection criteria This study has adopted the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (S1 PRISMA Checklist) . This study of all clinical trials that included the effect of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.